ZEVASKYN ® (prademagene zamikeracel) is an autologous cell sheet-based gene therapy indicated for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis ...

While enrollment in Medicare Advantage has increased over time and allows payers to offer extra benefits to beneficiaries, the program may be contributing to barriers and disruptions to care according ...